David Greenwood
#171,893
Most Influential Person Now
David Greenwood's AcademicInfluence.com Rankings
David Greenwoodbiology Degrees
Biology
#14154
World Rank
#17836
Historical Rank
Microbiology
#899
World Rank
#989
Historical Rank

Download Badge
Biology
David Greenwood's Degrees
- PhD Microbiology University of Manchester
- Masters Medical Microbiology University of Manchester
- Bachelors Biomedical Sciences University of Manchester
Why Is David Greenwood Influential?
(Suggest an Edit or Addition)David Greenwood's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. (1987) (156)
- Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. (1995) (118)
- In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. (1981) (111)
- Microbiological properties of teicoplanin. (1988) (84)
- Comparison of the Responses of Escherichia coli and Proteus mirabilis to Seven β-Lactam Antibiotics (1973) (82)
- The quinine connection. (1992) (80)
- FL 1060: a new beta-lactam antibiotic with novel properties (1973) (65)
- The response of Escherichia coli to ciprofloxacin and norfloxacin. (1987) (62)
- Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis (1995) (55)
- Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency (1980) (45)
- An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis. (1993) (44)
- Antibiotic-induced surface changes in microorganisms demonstrated by scanning electron microscopy. (1969) (44)
- An in vitro model of the urinary bladder. (1978) (42)
- The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. (1987) (40)
- Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. (1976) (39)
- A twelve channel bacterial growth monitoring system. (1973) (38)
- Trimodal Response of Escherichia coli and Proteus mirabilis to Penicillins (1970) (37)
- In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. (1993) (36)
- Scanning electron microscopy of Staphyloccus aureus exposed to some common anti-staphylococcal agents. (1972) (36)
- Scanning electronmicroscopy of Staphylococcus aureus and Enterococcus faecalis exposed to daptomycin. (1989) (32)
- A comparison of the effects of ampicillin on Escherichia coli and proteus mirabilis. (1969) (32)
- Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids (1978) (31)
- Characterization of β-lactamases in clinical isolates of Bacteroides (1986) (31)
- Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder. (1973) (31)
- Antibiotic resistance in enterococci. (1989) (30)
- A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin. (1987) (29)
- The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins. (1972) (29)
- Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. (1999) (29)
- An investigation of β-lactamases from clinical isolates of Bacteroides species (1992) (29)
- The two sites of penicillin action in Escherichia coli. (1973) (27)
- Antibacterial Agents: Basis of Action (2001) (27)
- Resistance to antimicrobial agents: a personal view. (1998) (27)
- In Vitro Model Simulating the Form of Exposure of Bacteria to Antimicrobial Drugs Encountered in Infection (1979) (26)
- Deadly Companions: How Microbes Shaped our History (2008) (26)
- In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin (1981) (25)
- Phenotypic resistance to antimicrobial agents. (1985) (23)
- Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem. (1986) (23)
- Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis (2021) (23)
- Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis. (1996) (22)
- The activity of polymyxins against dense populations of Escherichia coli. (1975) (21)
- The response of Pseudomonas aeruginosa to azlocillin, ticarcillin and cefsulodin. (1983) (21)
- The trometamol salt of fosfomycin: microbiological evaluation. (1987) (21)
- Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases. (1976) (21)
- Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics. (1976) (21)
- A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics. (1982) (20)
- Dual-Action Cephalosporin Utilizing a Novel Therapeutic Principle (1976) (19)
- Comparative growth of Bacteroides species in various anaerobic culture media. (1985) (18)
- Potent Combinations of β-Lactam Antibiotics using the β-Lactamase Inhibition Principle (1975) (18)
- Factors influencing the activity of the trometamol salt of fosfomycin (1986) (18)
- Detection of penicillin tolerance in streptococci. (1983) (18)
- An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor. (1979) (17)
- Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli (1992) (17)
- Antimicrobial Drugs: Chronicle of a twentieth century medical triumph (2008) (17)
- Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid. (1985) (16)
- Differential response to benzylpenicillin in vivo of tolerant and non-tolerant variants of Streptococcus sanguis II. (1990) (15)
- An in-vitro model simulating the hydrokinetic aspects of the treatment of bacterial cystitis. (1985) (15)
- Comparative antipseudomonal activity of some newer beta-lactam agents (1982) (15)
- Fosfomycin trometamol: Activity in vitro against urinary tract pathogens (2005) (15)
- The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin. (1984) (14)
- Activity of FL 1060, a new β-lactam antibiotic, against urinary tract pathogens (1974) (14)
- Is your dosage really necessary? Antibiotic dosage in urinary infection. (1977) (14)
- Interactions between fusidic acid and penicillins. (1973) (14)
- Factors Governing the Emergence of Resistance to Nalidixic Acid in Treatment of Urinary Tract Infection (1977) (14)
- The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder. (1974) (13)
- In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties. (1982) (13)
- Effect of Osmolality on the Response of Escherichia coli to Mecillinam (1976) (13)
- Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria (1981) (13)
- Resistance Categories of Enterobacteria to β-Lactam Antibiotics (1975) (13)
- Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis (1986) (12)
- Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder. (1975) (12)
- Relevance of in vitro synergy to therapy: does synergy between diaminopyrimidines and sulphonamides operate at concentrations achievable in urine? (1979) (12)
- The antibacterial activity of hexamine (methenamine), hexamine hippurate and hexamine mandelate (1981) (12)
- The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin. (1988) (11)
- Current Chemotherapy (1978) (11)
- Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria. (1977) (10)
- Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection. (1978) (10)
- Antibiotics of the beta-lactam group. (1982) (10)
- Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies. (1973) (9)
- Detection of antibiotic resistance in vitro. (2000) (9)
- The response of Staphylococcus aureus to benzylpenicillin. (1979) (9)
- Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder. (1976) (9)
- Differential Effects of Benzylpenicillin and Ampicillin on Escherichia coli and Proteus mirabilis in Conditions Simulating Those of the Urinary Bladder (1970) (9)
- An Overview of the Response of Bacteria to β-Lactam Antibiotics (1986) (9)
- Isoelectric focusing of beta-lactamases on cellulose acetate membranes. (1983) (9)
- Comparative Antipseudomonal Activity of Some Newer Lactam Agents (9)
- Activity of Cefazolin Against Dense Populations of Enterobacteria (1975) (9)
- Fosfomycin trometamol and the single-dose treatment of cystitis. (1994) (9)
- Lysis enhancement: a novel form of interaction between beta-lactam antibiotics. (1975) (8)
- Activity of teicoplanin against gram-negative anaerobes. (1988) (8)
- Tarnished gold: sixty years of antimicrobial drug use and misuse. (1995) (8)
- Distinctive outer membrane protein and lipopolysaccharide composition of Bacteroides fragilis strains that produce metallo-beta-lactamase. (1997) (8)
- Fixed or variable concentrations of βlactamase inhibitors in in-vitro tests? (1996) (8)
- Comparative activity of LY146032 against anaerobic cocci (1987) (8)
- Tolerance to penicillin in streptococci of viridans group. (1989) (7)
- An investigation of beta-lactamases from clinical isolates of Bacteroides species. (1992) (7)
- Fosfomycin and fosmidomycin (2011) (7)
- Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis (1984) (7)
- Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin. (1988) (7)
- FL1060: a new beta-lactam antibiotic withnovel properties (1973) (7)
- In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin. (1978) (6)
- Action and interaction of penicillin and gentamicin on enterococci. (1979) (6)
- Antibiotic effects in vitro and the prediction of clinical response. (1997) (6)
- Interactions between antibacterial agents of the quinolone group and nitrofurantoin. (1988) (6)
- TREATMENT OF ACUTE BACTERIAL CYSTITIS: ECONOMY VERSUS EFFICACY (1980) (6)
- In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteria (1982) (6)
- The scientific basis of antimicrobial chemotherapy : Thirty-eighth Symposium of the Society for General Microbiology, held at the University of Nottingham Medical School, September 1985 (1985) (6)
- The Microbiological and Pharmacokinetic Profile of an Antibacterial Agent Useful for the Single-Dose Therapy of Urinary Tract Infection (1987) (6)
- Effect of growth conditions and storage on the specific activity of beta-lactamases of Bacteroides spp. (1990) (5)
- Use of an in Vitro Model of the Urinary Bladder in the Investigation of Bacterial Response to Antibiotics (1976) (5)
- The responses of Escherichia coli to nalidixic acid. (1978) (5)
- Characterization of β-Lactamases ofPrevotellaspecies (1996) (5)
- Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem. (1987) (5)
- Enterococcus faecalis exposed to daptomycin (4)
- Changes in β-lactam antibiotic susceptibility and β-lactamase production of clinical isolates of Bacleroides and Prevotella species over a 9 year period (1996) (4)
- The Alteration of Microbial Growth Curves by Antibiotics (1985) (4)
- β-Lactam antibiotics (2010) (4)
- What's the use of susceptibility testing? (1997) (4)
- Comparison of the response ofEscherichia coli to fosfomycin and fosmidomycin (1987) (4)
- Antimicrobial susceptibility testing: are we wasting our time? (1993) (4)
- Factors affecting antibiotic concentrations in bladder urine. (1980) (4)
- Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group. (1984) (4)
- The antibacterial activity of Rowatinex. (1982) (4)
- Comparative InVitro Activities ofCefotaxime andCeftizoxime (FK749): NewCephalosporins withExceptional Potency (1980) (4)
- Correlations Between Methods for the Measurement of Antibiotic Synergy (1981) (3)
- Changes in beta-lactam antibiotic susceptibility and beta-lactamase production of clinical isolates of Bacteroides and Prevotella species over a 9 year period. (1996) (3)
- Comparative susceptibility of cefminox and cefoxitin to beta-lactamases of Bacteroides spp. (1991) (3)
- The effect of zinc ions on the activity of metallo-beta-lactamases of Bacteroides fragilis. (1997) (3)
- Letter: Co-trimoxazole and cephalexin in urinary tract infection. (1976) (3)
- Antibiotic resistance in enterococci in Nottingham. (1990) (3)
- The comparative activity of fosfomycin trometamol against organisms isolated from infected urines (2005) (3)
- An in vitro model for assessing optimum antibiotic dosage in urinary tract infection (2005) (3)
- The influence of anaerobiosis on the activity of fosfomycin trometamol (2005) (3)
- In vitro activity of cefotaxime (1979) (2)
- Turbidimetric response of Staphylococcus aureus and Enterococcus faecalis to daptomycin. (1988) (2)
- Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests? (1996) (2)
- The influence of chlorine and sulphonate substituents on the visible absorption maxima of some azo dyes (1986) (2)
- CHAPTER 13 – β-Lactam antibiotics: cephalosporins (2010) (2)
- Activity of fosmidomycin in an in vitro model of the treatment of bacterial cystitis (1987) (2)
- Comparative stability of meropenem against beta-lactamases from Bacteroides spp. (1993) (2)
- An overview of the response of bacteria to beta-lactam antibiotics. (1986) (2)
- Comparative Stability of Meropenem against β-Lactamases from Bacteroides spp. (1993) (2)
- Phenotypic variability and sensitivity tests: carry on regardless. (1991) (2)
- Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens. (1974) (2)
- Biochemistry and Molecular Biology of Antimicrobial Drug Action, 5th edition (2001) (2)
- Laboratory evaluation of pirbenicillin, a new penicillin with antipseudomonal activity. (1977) (2)
- The activity of polymyxins against Escherichia coli in an in-vitro model of the urinary bladder. (1977) (2)
- The assessment of antimicrobial activity in an in-vitro model of the treatment of bacterial cystitis. (1984) (2)
- The other GMP: good manufacturing practice and its importance in the validation of constructed pharmaceutical facilities (2005) (2)
- The activity of pipemidic acid and piromidic acid against Escherichia coli in static culture and in conditions stimulating the treatment of bacterial cystitis. (1978) (2)
- hydrolyse cefoxitin, latamoxef and imipenem (1986) (2)
- Characterization of beta-lactamases in clinical isolates of Bacteroides. (1986) (2)
- Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. (1975) (2)
- 63 – Helminths: Intestinal worm infections; filariasis; schistosomiasis; hydatid disease (2012) (2)
- InVitro Activity ofCeftizoxime Against Bacteroides fragilis: Comparison withBenzylpenicillin , Cephalothin, andCefoxitin (1981) (2)
- 6 – TRIMETHOPRIM PLUS SULPHAMETHOXAZOLE: SYNERGIC OR ANTAGONISTIC COMBINATION? (1977) (2)
- 62 – Protozoa: Malaria; toxoplasmosis; cryptosporidiosis; amoebiasis; trypanosomiasis; leishmaniasis; giardiasis; trichomoniasis (2012) (1)
- Resistance categories of enterobacteria to beta-lactam antibiotics. (1975) (1)
- Antibacterial agents: susceptibility In Vitro and In Vivo (2001) (1)
- Turbidimetric study of the effect of inoculum density on the response of Escherichia coli to gentamicin under aerobic and anaerobic conditions. (1991) (1)
- The Influence of Chlorine and Sulphonate Substituents on the Visible Absorption Maxima of Some Azo Dyes. (1986) (1)
- Variety in the response of Escherichia coli to erythromycin. (1972) (1)
- Turbidimetric response ofStaphylococcus aureus andEnterococcus faecalis to daptomycin (1988) (1)
- Strain variation in the response of Pseudomonas aeruginosa to carbenicillin. (1980) (1)
- Lords a-leaping: the Soulsby report on antimicrobial drug resistance. (1998) (1)
- Prophylactic vancomycin in very-low-birthweight infants (1992) (1)
- Additional characteristics of Bacteroides fragilis carbapenemases belonging to group 3a (1997) (1)
- Response of escherichia coli to beta-lactam antibiotics: Effect of the concomitant presence of staphylococci exhibiting inducible beta-lactamase activity (2005) (1)
- Relationship of beta-lactamase production to growth phase inBacteroides species (1985) (1)
- History of Antimalarial Agents (2003) (1)
- The in vitro activity of ceftezol (demethylcefazolin) against dense populations of Escherichia coli. (1976) (1)
- In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli. (1981) (1)
- United States Patent ( 19 ) Greenwood et al . ( 54 ) ANIONIC DYE HAVING HIGH WATER-FASTNESS (2017) (0)
- Activity of the Trometamol Salt of Fosfomycin in the Treatment of Bacterial Cystitis an In vitro Model of (1986) (0)
- Osmotic effects in sensitivity tests using beta-lactam antibiotics. (1978) (0)
- Gentamicin assay in the presence of imipenem. (1986) (0)
- S c a n n i n g e I ec t r o n m i c r osc o p y of Staph yo co ccus aureus and Enterococcus faecalis exposed to daptomycin (1989) (0)
- Assessment of Susceptibility of Ampicillin-Resistant Enterobacteria to Cephalosporins (1975) (0)
- Newer Antibiotics Active Against Bacteroides Fragilis: Comparison with Older Agents (1987) (0)
- RATIONAL CHOICE OF ANTIBIOTIC (1976) (0)
- Strategies for counteracting resistance to antibacterial agents. (1986) (0)
- A micro-chamber for continuous microscopic monitoring of anaerobic bacteria. (1985) (0)
- The clinical laboratory as an aid in chemotherapy of infectious disease (1978) (0)
- Prospects for New Antibiotics: Keeping One Step Ahead (1985) (0)
- The comparative activity of fosfomycin against organisms isolated from infected urines (1992) (0)
- Monitoring treatment with aminoglycoside antibiotics. (1993) (0)
- Studies on the emergence of resistance to lomefloxacin in vitro (1989) (0)
- Simulating Those of the Urinary Bladder (1970) (0)
- Magic Bullets, Lost Horizons. The Rise and Fall of Antibiotics S. G. B. Amyes. Taylor & Francis, London, UK, 2001. ISBN 0-415-27203-3. 262 pp. (2002) (0)
- Action andinteraction ofpenicillin andgentamicin on enterococci (1979) (0)
- Protective effect of Bacteroides fragilis metallo-β-lactamases on the susceptibility of co-pathogens to carbapenems in vitro (1997) (0)
- Penicillin and the site of wall growth in Gram-negative bacilli (1973) (0)
- Osmotic effects in sensitivity tests using β-lactam antibiotics (1978) (0)
- Fosfomycin Trometamol: A Microbiological Evaluation (1988) (0)
- Tolerance topenicillin instreptococci ofviridans group (1989) (0)
- Lois N. Magner, A History of Infectious Diseases and the Microbial World (2010) (0)
- MECILLINAM (1976) (0)
- Trivial pursuits: a game microbiologists play (1987) (0)
- A Practical Guide to Clinical Bacteriology (1995) (0)
- The pros and cons of beta-lactam antibiotics: Profusion and confusion (1982) (0)
- In vitro activity of cefotaxine. (1979) (0)
This paper list is powered by the following services: